Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioScience Health Innovations (BHIC) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to -$0.0.

  • BioScience Health Innovations' EPS (Basic) fell 10799.89% to -$0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year change of 0.0%. This contributed to the annual value of $0.0 for FY2024, which is 12074.69% up from last year.
  • As of Q3 2025, BioScience Health Innovations' EPS (Basic) stood at -$0.0, which was down 10799.89% from $0.01 recorded in Q2 2025.
  • Over the past 5 years, BioScience Health Innovations' EPS (Basic) peaked at $0.01 during Q3 2024, and registered a low of -$0.01 during Q2 2022.
  • Over the past 5 years, BioScience Health Innovations' median EPS (Basic) value was -$0.0 (recorded in 2023), while the average stood at -$0.0.
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 139217.82% in 2022, then surged by 87540.37% in 2025.
  • Quarter analysis of 5 years shows BioScience Health Innovations' EPS (Basic) stood at -$0.0 in 2021, then tumbled by 105.25% to -$0.01 in 2022, then surged by 78.53% to -$0.0 in 2023, then skyrocketed by 120.89% to $0.0 in 2024, then tumbled by 436.87% to -$0.0 in 2025.
  • Its last three reported values are -$0.0 in Q3 2025, $0.01 for Q2 2025, and $0.01 during Q1 2025.